The type I interferon, interferon-α (IFNα), is expressed in islets of T1D patients5, and antibodies neutralizing different isoforms of IFNα prevent T1D development in individuals with polyglandular autoimmune syndrome type 16. Here, IFNA17 is linked to type 1 diabetes mellitus.